Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Sergio Triscari, Vittorio Lenzo, Alberto Sardella, Pasquale Caponnetto, Anna Galati, Patricia Lupica, Domenica Tasca, Stefano Muratore, Pietro Marano, Filippo Caraci, Maria C. Quattropani
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Parkinson’s disease and parkinsonism
10.1016/j.amjmed.2019.03.001 · 2019
The epidemiology of Parkinson’s disease
10.1016/s0140-6736(23)01419-8 · 2024
Impulse control disorders in Parkinson’s disease: definition, epidemiology, risk factors, neurobiology and management
10.1016/s1353-8020(09)70847-8 · 2009
Impulse control disorders in Parkinson’s disease: Epidemiology, pathogenesis and therapeutic strategies
10.3389/fpsyt.2021.635494 · 2021
Impulse control disorders in patients with Parkinson’s disease receiving dopamine replacement therapy: evidence and implications for the addictions field
10.1111/j.1360-0443.2010.03218.x · 2011
Impulse control disorder in parkinson’s disease: A meta-analysis of cognitive, affective, and motivational correlates
10.3389/fneur.2018.00654 · 2018
Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
10.1136/jnnp-2015-311827 · 2016
A multicenter comparative study of impulse control disorder in latin american patients with parkinson disease
10.1097/wnf.0000000000000202 · 2017
Management of impulse control and related disorders in parkinson’s disease: an expert consensus
10.1002/mds.29700 · 2024
Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients
10.1001/archneurol.2010.65 · 2010
Impulsivity and compulsivity in drug‐naïve patients with Parkinson’s disease
10.1002/mds.23501 · 2011
Impulse control disorders in Parkinson’s disease: don’t set your mind at rest by self‐assessments
10.1111/ene.12646 · 2015
Metacognition, executive control, self-regulation, and other more mysterious mechanisms
1987
How to measure metacognition
10.3389/fnhum.2014.00443 · 2014
Unresolved referenced work
2009
A short form of the metacognitions questionnaire: Properties of the MCQ-30
10.1016/s0005-7967(03)00147-5 · 2004
Modelling cognition in emotional disorder: The S-REF model
10.1016/s0005-7967(96)00050-2 · 1996
Breaking the cybernetic code: Understanding and treating the human metacognitive control system to enhance mental health
10.3389/fpsyg.2019.02621 · 2019
Dysfunctional metacognition across psychopathologies: A meta-analytic review
10.1016/j.eurpsy.2017.05.029 · 2017
Metacognition in addictive behaviors
10.1016/j.addbeh.2014.08.002 · 2015
Metacognitive beliefs in addictive behaviours: A systematic review
10.1016/j.addbeh.2018.05.018 · 2018
Movement disorder society unified parkinson’s disease rating scale motor examination retains its 2‐Domain profile in both on and off states
10.1002/mdc3.13566 · 2022
Parkinsonism: onset, progression, and mortality
10.1212/wnl.17.5.427 · 1967
Montreal cognitive assessment (MoCA)
2005
Italian validation of montreal cognitive assessment
10.1027/1015-5759/a000217 · 2015
The Frontal Assessment Battery (FAB): normative values in an Italian population sample
10.1007/s10072-005-0443-4 · 2005
DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care
10.1002/wps.20154 · 2014
Systematic review of levodopa dose equivalency reporting in Parkinson’s disease
10.1002/mds.23429 · 2010
Levodopa dose equivalency in parkinson’s disease: updated systematic review and proposals
10.1002/mds.29410 · 2023
Questionnaire for impulsive‐compulsive disorders in Parkinson’s Disease–Rating Scale
10.1002/mds.24023 · 2012
Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS) in an Italian Parkinson’s disease cohort
10.1007/s10072-024-07304-2 · 2024
Psychometric properties of the Italian version of the Short Form of the Metacognitions Questionnaire (MCQ-30)
2014
Metacognitions questionnaire–short form (Italian version, MCQ-30)
2014
Unresolved referenced work
Kept as external metadata until matched
Controlling the false discovery rate: A practical and powerful approach to multiple testing
10.1111/j.2517-6161.1995.tb02031.x · 1995
Benjamini–hochberg method
10.1007/978-1-4419-9863-7_1215 · 2013
The montreal cognitive assessment, moCA: A brief screening tool for mild cognitive impairment
10.1111/j.1532-5415.2005.53221.x · 2005
Longitudinal analysis of impulse control disorders in Parkinson disease
10.1212/wnl.0000000000005816 · 2018
Distress in Parkinson's disease: contributions of disease factors and metacognitive style
10.1192/bjp.187.2.182 · 2005
Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease
10.1016/j.jpsychores.2015.05.001 · 2015
Impulse control disorder in Parkinson's disease is associated with abnormal frontal value signalling
10.1093/brain/awad162 · doi-reference
Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder
10.1093/brain/awaa198 · doi-reference
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease
10.1002/mds.27139 · doi-reference
Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease
10.1212/wnl.0000000000001619 · doi-reference
Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
10.1093/brain/awr003 · doi-reference
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
10.1093/brain/awp054 · doi-reference
Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [11C]-PHNO PET study
10.1016/j.parkreldis.2021.06.025 · doi-reference
Impulse control disorders in Parkinson's disease. A brief and comprehensive review
10.3389/fneur.2019.00351 · doi-reference
A brief history of metacognitive therapy: From cognitive science to clinical practice
10.1016/j.cbpra.2021.11.002 · doi-reference
Metacognitive beliefs and addictions: A systematic review and meta-analysis with emphasis on the mediating role of desire thinking
10.1016/j.addbeh.2026.108613 · doi-reference
Metacognitive beliefs, mood symptoms, and fatigue four years after stroke: An explorative study
10.1371/journal.pone.0305896 · doi-reference
Association between metacognition and mood symptoms poststroke
10.1177/0891988716640374 · doi-reference
The association between maladaptive metacognitive beliefs and emotional distress in people living with amyotrophic lateral sclerosis
10.3389/fpsyg.2021.609068 · doi-reference
Metacognitive beliefs and illness perceptions are associated with emotional distress in people with epilepsy
10.1016/j.yebeh.2018.07.008 · doi-reference
The clinical utility of metacognitive beliefs and processes in emotional distress in people with multiple sclerosis
10.1016/j.jpsychores.2017.11.014 · doi-reference